Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling

Lei Xiong, Ji Ung Jung, Hao Han Guo, Jin Xiu Pan, Xiang Dong Sun, Lin Mei, Wencheng Xiong

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Bone homeostasis depends on the functional balance of osteoblasts (OBs) and osteoclasts (OCs). Lrp4 is a transmembrane protein that is mutated in patients with high bone mass. Loss of Lrp4 in OB-lineage cells increases bone mass by elevating bone formation by OBs and reducing bone resorption by OCs. However, it is unclear how Lrp4 deficiency in OBs impairs osteoclastogenesis. Here, we provide evidence that loss of Lrp4 in the OB lineage stabilizes the prorenin receptor (PRR) and increases PRR/V-ATPase-driven ATP release, thereby enhancing the production of the ATP derivative adenosine. Both pharmacological and genetic inhibition of adenosine-2A receptor (A2AR) in culture and Lrp4 mutant mice diminishes the osteoclastogenic deficit and reduces trabecular bone mass. Furthermore, elevated adenosine-A2AR signaling reduces receptor activator of nuclear factor κB (RANK)-mediated osteoclastogenesis. Collectively, these results identify a mechanism by which osteoblastic Lrp4 controls osteoclastogenesis, reveal a cross talk between A2AR and RANK signaling in osteoclastogenesis, and uncover an unrecognized pathophysiological mechanism of high-bone-mass disorders.

Original languageEnglish (US)
Pages (from-to)761-778
Number of pages18
JournalJournal of Cell Biology
Volume216
Issue number3
DOIs
StatePublished - Jan 1 2017

Fingerprint

Purinergic P1 Receptors
Osteoblasts
Osteogenesis
Adenosine
Adenosine Triphosphate
Bone and Bones
Osteoclasts
Bone Resorption
Cytoplasmic and Nuclear Receptors
Adenosine Triphosphatases
Homeostasis
Pharmacology
Proteins

ASJC Scopus subject areas

  • Cell Biology

Cite this

Xiong, L., Jung, J. U., Guo, H. H., Pan, J. X., Sun, X. D., Mei, L., & Xiong, W. (2017). Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. Journal of Cell Biology, 216(3), 761-778. https://doi.org/10.1083/jcb.201608002

Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. / Xiong, Lei; Jung, Ji Ung; Guo, Hao Han; Pan, Jin Xiu; Sun, Xiang Dong; Mei, Lin; Xiong, Wencheng.

In: Journal of Cell Biology, Vol. 216, No. 3, 01.01.2017, p. 761-778.

Research output: Contribution to journalArticle

Xiong, L, Jung, JU, Guo, HH, Pan, JX, Sun, XD, Mei, L & Xiong, W 2017, 'Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling', Journal of Cell Biology, vol. 216, no. 3, pp. 761-778. https://doi.org/10.1083/jcb.201608002
Xiong, Lei ; Jung, Ji Ung ; Guo, Hao Han ; Pan, Jin Xiu ; Sun, Xiang Dong ; Mei, Lin ; Xiong, Wencheng. / Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. In: Journal of Cell Biology. 2017 ; Vol. 216, No. 3. pp. 761-778.
@article{e8aa69e863104857b7323586acfd1044,
title = "Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling",
abstract = "Bone homeostasis depends on the functional balance of osteoblasts (OBs) and osteoclasts (OCs). Lrp4 is a transmembrane protein that is mutated in patients with high bone mass. Loss of Lrp4 in OB-lineage cells increases bone mass by elevating bone formation by OBs and reducing bone resorption by OCs. However, it is unclear how Lrp4 deficiency in OBs impairs osteoclastogenesis. Here, we provide evidence that loss of Lrp4 in the OB lineage stabilizes the prorenin receptor (PRR) and increases PRR/V-ATPase-driven ATP release, thereby enhancing the production of the ATP derivative adenosine. Both pharmacological and genetic inhibition of adenosine-2A receptor (A2AR) in culture and Lrp4 mutant mice diminishes the osteoclastogenic deficit and reduces trabecular bone mass. Furthermore, elevated adenosine-A2AR signaling reduces receptor activator of nuclear factor κB (RANK)-mediated osteoclastogenesis. Collectively, these results identify a mechanism by which osteoblastic Lrp4 controls osteoclastogenesis, reveal a cross talk between A2AR and RANK signaling in osteoclastogenesis, and uncover an unrecognized pathophysiological mechanism of high-bone-mass disorders.",
author = "Lei Xiong and Jung, {Ji Ung} and Guo, {Hao Han} and Pan, {Jin Xiu} and Sun, {Xiang Dong} and Lin Mei and Wencheng Xiong",
year = "2017",
month = "1",
day = "1",
doi = "10.1083/jcb.201608002",
language = "English (US)",
volume = "216",
pages = "761--778",
journal = "Journal of Cell Biology",
issn = "0021-9525",
publisher = "Rockefeller University Press",
number = "3",

}

TY - JOUR

T1 - Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling

AU - Xiong, Lei

AU - Jung, Ji Ung

AU - Guo, Hao Han

AU - Pan, Jin Xiu

AU - Sun, Xiang Dong

AU - Mei, Lin

AU - Xiong, Wencheng

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Bone homeostasis depends on the functional balance of osteoblasts (OBs) and osteoclasts (OCs). Lrp4 is a transmembrane protein that is mutated in patients with high bone mass. Loss of Lrp4 in OB-lineage cells increases bone mass by elevating bone formation by OBs and reducing bone resorption by OCs. However, it is unclear how Lrp4 deficiency in OBs impairs osteoclastogenesis. Here, we provide evidence that loss of Lrp4 in the OB lineage stabilizes the prorenin receptor (PRR) and increases PRR/V-ATPase-driven ATP release, thereby enhancing the production of the ATP derivative adenosine. Both pharmacological and genetic inhibition of adenosine-2A receptor (A2AR) in culture and Lrp4 mutant mice diminishes the osteoclastogenic deficit and reduces trabecular bone mass. Furthermore, elevated adenosine-A2AR signaling reduces receptor activator of nuclear factor κB (RANK)-mediated osteoclastogenesis. Collectively, these results identify a mechanism by which osteoblastic Lrp4 controls osteoclastogenesis, reveal a cross talk between A2AR and RANK signaling in osteoclastogenesis, and uncover an unrecognized pathophysiological mechanism of high-bone-mass disorders.

AB - Bone homeostasis depends on the functional balance of osteoblasts (OBs) and osteoclasts (OCs). Lrp4 is a transmembrane protein that is mutated in patients with high bone mass. Loss of Lrp4 in OB-lineage cells increases bone mass by elevating bone formation by OBs and reducing bone resorption by OCs. However, it is unclear how Lrp4 deficiency in OBs impairs osteoclastogenesis. Here, we provide evidence that loss of Lrp4 in the OB lineage stabilizes the prorenin receptor (PRR) and increases PRR/V-ATPase-driven ATP release, thereby enhancing the production of the ATP derivative adenosine. Both pharmacological and genetic inhibition of adenosine-2A receptor (A2AR) in culture and Lrp4 mutant mice diminishes the osteoclastogenic deficit and reduces trabecular bone mass. Furthermore, elevated adenosine-A2AR signaling reduces receptor activator of nuclear factor κB (RANK)-mediated osteoclastogenesis. Collectively, these results identify a mechanism by which osteoblastic Lrp4 controls osteoclastogenesis, reveal a cross talk between A2AR and RANK signaling in osteoclastogenesis, and uncover an unrecognized pathophysiological mechanism of high-bone-mass disorders.

UR - http://www.scopus.com/inward/record.url?scp=85021848807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021848807&partnerID=8YFLogxK

U2 - 10.1083/jcb.201608002

DO - 10.1083/jcb.201608002

M3 - Article

C2 - 28193701

AN - SCOPUS:85021848807

VL - 216

SP - 761

EP - 778

JO - Journal of Cell Biology

JF - Journal of Cell Biology

SN - 0021-9525

IS - 3

ER -